ImmVira Pharma Co. Ltd Report issue

For profit Phase 1 Phase 2
Founded: Shenzhen China (2015)

Organization Overview

First Clinical Trial
2020
NCT04370587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ImmVira Pharma Co. Ltd